Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease

P. Kisfali, N. Polgár, E. Sáfrány, K. Sümegi, B. I. Melegh, J. Bene, Á Wéber, K. Hetyésy, B. Melegh

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Metabolic syndrome is characterized primarily by abdominal obesity, high triglyceride and low HDL cholesterol levels, elevated blood pressure, and increased fasting glucose levels, which are often associated with coronary heart diseases. Several factors, such as physical inactivity, age, and several endocrine and genetic factors can increase the risk of the development of the disease. Gathered evidence shows, that metabolic syndrome is not only a risk factor for cardio vascular disease, but often both of them have the same shared susceptibility genes, as several genetic variants have shown a predisposition to both diseases. Due to the spread of robust genome wide association studies, the number of candidate genes in metabolic syndrome and coronary heart disease susceptibility increases very rapidly. From the growing spectrum of the genes influencing lipid metabolism (like the LPL; PPARA; APOE; APOAI/CIII/AIV genecluster and APOA5), the current review focuses on shared susceptibility variants involved in triglyceride metabolism and consequently the effects on the circulating triglyceride levels. As the elevated levels of triglycerides can be associated with disease phenotypes, some of these SNPs can have susceptibility features in both metabolic syndrome and in coronary heart disease, thereby some of them can even represent a kind of susceptibility link between metabolic syndrome and coronary artery disease. 2010 Bentham Science Publishers Ltd.

Original languageEnglish
Pages (from-to)3533-3541
Number of pages9
JournalCurrent Medicinal Chemistry
Volume17
Issue number30
DOIs
Publication statusPublished - 2010

Fingerprint

Coronary Artery Disease
Triglycerides
Genes
Coronary Disease
Abdominal Obesity
Genome-Wide Association Study
Disease Susceptibility
Apolipoproteins E
Vascular Diseases
Lipid Metabolism
HDL Cholesterol
Single Nucleotide Polymorphism
Fasting
Blood pressure
Blood Pressure
Phenotype
Glucose
Metabolism

Keywords

  • Atherosclerosis
  • Gene
  • Hypertriglyceridemia
  • Metabolic syndrome
  • Snp

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease. / Kisfali, P.; Polgár, N.; Sáfrány, E.; Sümegi, K.; Melegh, B. I.; Bene, J.; Wéber, Á; Hetyésy, K.; Melegh, B.

In: Current Medicinal Chemistry, Vol. 17, No. 30, 2010, p. 3533-3541.

Research output: Contribution to journalArticle

@article{318f9f9dd60c49c9b9f74d610c664b8b,
title = "Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease",
abstract = "Metabolic syndrome is characterized primarily by abdominal obesity, high triglyceride and low HDL cholesterol levels, elevated blood pressure, and increased fasting glucose levels, which are often associated with coronary heart diseases. Several factors, such as physical inactivity, age, and several endocrine and genetic factors can increase the risk of the development of the disease. Gathered evidence shows, that metabolic syndrome is not only a risk factor for cardio vascular disease, but often both of them have the same shared susceptibility genes, as several genetic variants have shown a predisposition to both diseases. Due to the spread of robust genome wide association studies, the number of candidate genes in metabolic syndrome and coronary heart disease susceptibility increases very rapidly. From the growing spectrum of the genes influencing lipid metabolism (like the LPL; PPARA; APOE; APOAI/CIII/AIV genecluster and APOA5), the current review focuses on shared susceptibility variants involved in triglyceride metabolism and consequently the effects on the circulating triglyceride levels. As the elevated levels of triglycerides can be associated with disease phenotypes, some of these SNPs can have susceptibility features in both metabolic syndrome and in coronary heart disease, thereby some of them can even represent a kind of susceptibility link between metabolic syndrome and coronary artery disease. 2010 Bentham Science Publishers Ltd.",
keywords = "Atherosclerosis, Gene, Hypertriglyceridemia, Metabolic syndrome, Snp",
author = "P. Kisfali and N. Polg{\'a}r and E. S{\'a}fr{\'a}ny and K. S{\"u}megi and Melegh, {B. I.} and J. Bene and {\'A} W{\'e}ber and K. Hety{\'e}sy and B. Melegh",
year = "2010",
doi = "10.2174/092986710792927822",
language = "English",
volume = "17",
pages = "3533--3541",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "30",

}

TY - JOUR

T1 - Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease

AU - Kisfali, P.

AU - Polgár, N.

AU - Sáfrány, E.

AU - Sümegi, K.

AU - Melegh, B. I.

AU - Bene, J.

AU - Wéber, Á

AU - Hetyésy, K.

AU - Melegh, B.

PY - 2010

Y1 - 2010

N2 - Metabolic syndrome is characterized primarily by abdominal obesity, high triglyceride and low HDL cholesterol levels, elevated blood pressure, and increased fasting glucose levels, which are often associated with coronary heart diseases. Several factors, such as physical inactivity, age, and several endocrine and genetic factors can increase the risk of the development of the disease. Gathered evidence shows, that metabolic syndrome is not only a risk factor for cardio vascular disease, but often both of them have the same shared susceptibility genes, as several genetic variants have shown a predisposition to both diseases. Due to the spread of robust genome wide association studies, the number of candidate genes in metabolic syndrome and coronary heart disease susceptibility increases very rapidly. From the growing spectrum of the genes influencing lipid metabolism (like the LPL; PPARA; APOE; APOAI/CIII/AIV genecluster and APOA5), the current review focuses on shared susceptibility variants involved in triglyceride metabolism and consequently the effects on the circulating triglyceride levels. As the elevated levels of triglycerides can be associated with disease phenotypes, some of these SNPs can have susceptibility features in both metabolic syndrome and in coronary heart disease, thereby some of them can even represent a kind of susceptibility link between metabolic syndrome and coronary artery disease. 2010 Bentham Science Publishers Ltd.

AB - Metabolic syndrome is characterized primarily by abdominal obesity, high triglyceride and low HDL cholesterol levels, elevated blood pressure, and increased fasting glucose levels, which are often associated with coronary heart diseases. Several factors, such as physical inactivity, age, and several endocrine and genetic factors can increase the risk of the development of the disease. Gathered evidence shows, that metabolic syndrome is not only a risk factor for cardio vascular disease, but often both of them have the same shared susceptibility genes, as several genetic variants have shown a predisposition to both diseases. Due to the spread of robust genome wide association studies, the number of candidate genes in metabolic syndrome and coronary heart disease susceptibility increases very rapidly. From the growing spectrum of the genes influencing lipid metabolism (like the LPL; PPARA; APOE; APOAI/CIII/AIV genecluster and APOA5), the current review focuses on shared susceptibility variants involved in triglyceride metabolism and consequently the effects on the circulating triglyceride levels. As the elevated levels of triglycerides can be associated with disease phenotypes, some of these SNPs can have susceptibility features in both metabolic syndrome and in coronary heart disease, thereby some of them can even represent a kind of susceptibility link between metabolic syndrome and coronary artery disease. 2010 Bentham Science Publishers Ltd.

KW - Atherosclerosis

KW - Gene

KW - Hypertriglyceridemia

KW - Metabolic syndrome

KW - Snp

UR - http://www.scopus.com/inward/record.url?scp=77957979509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957979509&partnerID=8YFLogxK

U2 - 10.2174/092986710792927822

DO - 10.2174/092986710792927822

M3 - Article

C2 - 20738247

AN - SCOPUS:77957979509

VL - 17

SP - 3533

EP - 3541

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 30

ER -